memo - Magazine of European Medical Oncology

DNA damage repair – a new target for cancer therapy

• Editorial

Oliver E. Bechter

Interdisciplinary strategies in metastatic cancer patients

• Editorial

D. Öfner

10 Years CECOG

• CECOG News

Clinical importance of DNA repair inhibitors in cancer therapy

• Short Review

N. Hosoya, K. Miyagawa

Clinical implications of DNA repair genetic alterations in cancer

• Short Review

L. Gossage, M. Mohammed, S. Madhusudan

Disruption of telomere homeostasis as a new cancer treatment strategy

• Short Review

B.-S. Herbert

Role of interdisciplinary strategies in liver metastases

• Short Review

D. Öfner, W. Eisterer

Current role of interdisciplinary strategies in the treatment of pulmonary metastases

• Short Review

B. Akan, C. Bichler, D. Kandioler

Potentially curative strategies in peritoneal metastases

• Short Review

F. Kober, M. Karik, M. Hermann

Austrian Consensus on the surgical treatment of colorectal liver metastases

• Consensus Report

Dietmar Öfner, Thomas Grünberger, Wolfgang Eisterer

Challenges and pitfalls in HNPCC: a pedigree of an Austrian HNPCC family beyond four generations!

• Original Report

T. Winder, A. Mündlein, K. Gasser, G. Lingg, J. Walser, J. Karner-Hanusch, K. Dirschmid, H. Drexel, A. Lang

The expression of EGFR, HER2 and EpCam in Head and Neck squamous cell carcinomas

• Original Report

V. H. Schartinger, J. Schmutzhard, M. Wurm, I. M. Schwentner, P. Obrist, W. Oberaigner, G. M. Sprinzl

Lung cancer under 40

• CECOG Project

Matjaz Zwitter

Announcement

• Announcement